- Home
- MDGL vs XP Comparison
MDGL vs XP Comparison
Compare MDGL & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- XP
- Stock Information
- Founded
- MDGL 2011
- XP 2001
- Country
- MDGL United States
- XP Cayman Islands
- Employees
- MDGL N/A
- XP N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- MDGL Health Care
- XP Finance
- Exchange
- MDGL Nasdaq
- XP Nasdaq
- Market Cap
- MDGL 7.5B
- XP 7.3B
- IPO Year
- MDGL N/A
- XP 2019
- Fundamental
- Price
- MDGL $323.98
- XP $14.15
- Analyst Decision
- MDGL Buy
- XP Buy
- Analyst Count
- MDGL 10
- XP 6
- Target Price
- MDGL $354.75
- XP $20.33
- AVG Volume (30 Days)
- MDGL 317.3K
- XP 9.5M
- Earning Date
- MDGL 05-06-2025
- XP 05-20-2025
- Dividend Yield
- MDGL N/A
- XP 4.59%
- EPS Growth
- MDGL N/A
- XP 14.90
- EPS
- MDGL N/A
- XP 1.33
- Revenue
- MDGL $180,133,000.00
- XP $2,627,582,667.00
- Revenue This Year
- MDGL $228.41
- XP $19.77
- Revenue Next Year
- MDGL $73.44
- XP $12.85
- P/E Ratio
- MDGL N/A
- XP $10.33
- Revenue Growth
- MDGL N/A
- XP 14.10
- 52 Week Low
- MDGL $189.00
- XP $10.82
- 52 Week High
- MDGL $377.46
- XP $25.61
- Technical
- Relative Strength Index (RSI)
- MDGL 45.41
- XP 45.49
- Support Level
- MDGL $310.00
- XP $13.73
- Resistance Level
- MDGL $350.50
- XP $15.12
- Average True Range (ATR)
- MDGL 13.02
- XP 0.53
- MACD
- MDGL -1.72
- XP -0.15
- Stochastic Oscillator
- MDGL 34.52
- XP 21.74
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.